SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending as community members discuss its low float and potential for a short squeeze, with some comparing it to past runners. Discussions mention the possibility of a parabolic move if certain price levels are broken, drawing attention from traders looking for quick gains. The stock's price action and potential catalysts are being closely watched for further upward momentum.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending amidst discussions about defense contracts and laser technology applications, particularly related to the "Golden Dome" project. Community chatter highlights potential contract news and speculation around short positions, with some emphasizing the company's role in directed energy and defense systems. Investors are closely watching for updates that could catalyze a significant move in the stock.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending as chatter swirls around potential cannabis rescheduling, fueled by anticipated policy shifts. Community members are actively discussing the possibility of a short squeeze, while also considering the impact on the broader cannabis sector. The stock's movement is being closely watched in relation to other cannabis stocks like $YCBD and $ARBB, with some focusing on the potential for smaller floats to see significant gains.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as its community focuses on 'OG Memes' and a nostalgic return to the vibes of 2021, expressing bullish sentiment amid recent market activity. The community actively promotes $RAGE's potential for growth and highlights the importance of community support, while also speculating about possible exchange listings and a revival of Rage Comics.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community emphasizes its cultural movement, simple progress, and long-term vision, drawing parallels to Bitcoin but with a cannabis twist. Discussions highlight its roots in cannabis culture and a focus on positivity, creativity, and innovation within the crypto space, while emphasizing its presence on the Solana blockchain.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria is trending as traders discuss its high dividend yield and debate its long-term growth potential amid shifting consumer preferences. Community members are weighing the stock's defensive qualities against concerns about declining cigarette volumes, while also considering the impact of potential regulatory changes and Altria's moves in the cannabis and smoke-free product markets. Recent analyst ratings have also spurred discussion about the stock's near-term direction.

ETHZilla Corp. is a technology company in the decentralized finance (DeFi) industry, which intends to connect financial institutions, businesses, and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It continues to maintain the deployment and development of its biotech and gaming operations. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZilla Corporation is trending amidst discussions about its current strategy, including concerns about management decisions and potential dilution, with some shareholders calling for leadership changes. The stock's performance is closely tied to Ethereum's price, and the community is debating whether its current valuation reflects its asset holdings. There is also speculation about potential short squeezes and the impact of upcoming earnings.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

TEM is trending as community members discuss its potential in the AI-driven healthcare sector, with some pointing to potential tailwinds while others highlight a high valuation. Recent news, including new partnerships and FDA clearances, are fueling optimism, while technical analysis suggests key levels to watch for potential breakouts or pullbacks. Discussions also include possible impacts from broader market trends and potential insider selling.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending amid speculation of federal policy changes in the cannabis sector, particularly potential rescheduling, with investors weighing its potential impact on the company. Community discussions revolve around how ACB stands to benefit compared to its peers, while some caution that it may already be overvalued. Others point out that Aurora's established international presence positions it well for growth should favorable policy shifts occur.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

ARBK is trending due to recent volatility after a reverse stock split, with community members actively discussing its potential for a short squeeze given the low float. Some traders are eyeing a possible dead cat bounce, while others remain cautious due to the company's recent restructuring and delisting from the London Stock Exchange. The stock's movements are being closely watched in relation to Bitcoin's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Brokerages

Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have been given a consensus recommendation of "Buy" by the seven brokerages that are currently covering the company, MarketBeat.com...

Braidwell LP Invests $4.22 Million in Crescent Biopharma, Inc. $CBIO

Braidwell LP acquired a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange...

BVF Inc. IL Makes New Investment in Crescent Biopharma, Inc. $CBIO

BVF Inc. IL purchased a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and...

Fairmount Funds Management Llc Purchases 1,360,000 Shares of Crescent Biopharma (NASDAQ:CBIO) Stock

Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) Director Fairmount Funds Management Llc bought 1,360,000 shares of the stock in a transaction on Thursday, December 4th. The shares were...

Crescent Biopharma (NASDAQ:CBIO) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded shares of Crescent Biopharma from a "hold" rating to a "sell" rating in a research report on Saturday...

<ul class="summary-bullets"><li>Crescent Biopharma is partnering with the Chinese firm Kelun-Biotech to expand its oncology drug pipeline and accelerate its combination strategy.&nbsp;</li><li>The company also announced a $185 million private placement, expected to close around December 8.</li><li>Stocktwits retail sentiment for the stock was ‘extremely bullish’.</li></ul><a href="https://stocktwits.com/symbol/CBIO">Crescent Biopharma (CBIO)</a> announced a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co. to expand its pipeline of oncology drugs and speed up its combination strategy. The company also announced a $185 million private placement, expected to close around December 8.Shares of Crescent were up over 40% in pre-market trading.The company said it has three distinct programs that are expected to enter the clinic in 2026. In addition, the private financing will boost its cash runway.“We’re excited to share the tremendous progress we’ve made executing on our strategy of building a robust portfolio of next-generation oncology therapeutics," said Joshua Brumm, chief executive officer of Crescent.<h2 class="st-heading-2">Partnership Details</h2>The deal will allow Crescent exclusive rights to research, develop, and commercialize SKB105 (also known as CR-003) in the United States, Europe, and all markets excluding Greater China. This is an integrin beta-6 (ITGB6)-directed antibody-drug conjugate (ADC) with a topoisomerase payload.Meanwhile, Kelun-Biotech will obtain exclusive rights to research, develop, and commercialize CR-001 in Greater China, including mainland China, Hong Kong, Macau, and Taiwan. The drug is Crescent’s bispecific antibody that the company says has the potential to be foundational in immuno-oncology.Both Crescent and Kelun-Biotech will retain the right to independently develop CR-001 in combination with proprietary ADC pipeline assets.“CR-001, our PD-1 x VEGF bispecific antibody, has the potential to be a foundational immuno-oncology backbone and the partnership we announced with Kelun-Biotech today has enhanced our pipeline of ADCs and accelerated our efforts to deliver potentially best-in-class novel combination therapies,” said Brumm.<h2 class="st-heading-2">Retail Reaction</h2>Stocktwits retail sentiment for the stock changed from ‘neutral’ to ‘extremely bullish’ while message volume jumped to ‘extremely high’.<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_5_01_28_PM_png_71929a932d.webp" alt="Stocktwits retail sentiment for the stock is ‘extremely bullish’ while message volume remained ‘extremely high’."> One user noted they were ‘bullish’ on the stock, adding “In with a starter!”<stembedurl>https://stocktwits.com/KuruHabesha/message/638133096</stembedurl>Another said that the stock was long forgotten in their portfolio.<stembedurl>https://stocktwits.com/walkingprinter/message/638132752</stembedurl>Shares of Crescent Biopharma were down about 47% year-to-date but have gained almost 8% in the last month.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/why-tigr-stock-rose-premarket-trade-today/cLILDuARESm">Here’s Why TIGR Stock Rose In Premarket Today – And Retail Traders Think The Rally’s Just Starting</a>For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Researcher performing microbiology separator for PCR diagnosis test in pathology laboratory. 

The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today

Crescent Biopharma announced a strategic partnership with the Chinese firm Sichuan Kelun-Biotech Biopharmaceutical Co. to fast-track its global oncology pipeline. 

Equity

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Analysts

Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) has been given a consensus recommendation of "Buy" by the seven ratings firms that are currently covering the firm, Marketbeat.com reports...

Crescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded Crescent Biopharma from a "sell" rating to a "hold" rating in a report on Sunday...

Crescent Biopharma (NASDAQ:CBIO) Announces Earnings Results

Crescent Biopharma (NASDAQ:CBIO - Get Free Report) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.27) earnings per share (EPS) for the quarter, missing the...

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

CBIO
Crescent Biopharma Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest CBIO News

CBIOCrescent Biopharma Inc.